UPCC 04622 Dermatology Clinic Repository Study

Enrolling By Invitation
18 years - 99 years
All
2000 participants needed
1 Location

Brief description of study

The purpose of this study is to obtain blood and/or skin tissues from consenting subjects who have been diagnosed with Cutaneous T-cell lymphoma (CTCL), solid organ transplant rejection or GVHD that will be used for current and/or future research. This research may provide information about the causes of these diseases and novel treatment options.

Detailed description of study

The purpose of this study is to obtain blood and/or skin tissues from consenting subjects who have been diagnosed with Cutaneous T-cell lymphoma (CTCL), solid organ transplant rejection or GVHD that will be used for current and/or future research. This research may provide information about the causes of these diseases and novel treatment options.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research,Cutaneous T-cell lymphoma,CTCL
  • Age: 18 years - 99 years
  • Gender: All

Age of 18+ with a confirmed diagnosis of CTCL, solid organ transplant rejection or GVHD.

Updated on 22 Apr 2026. Study ID: 21-1523
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator